Kelly Plummer, Ph.d.

Kelly Plummer, Ph.d.

Morgan Lewis

Contact
View Bio
RSS

Latest Posts › Amgen

Share:

Blockbuster Biologics Review | Issue 26

Welcome to our quarterly update relating to biologics and biosimilars, including post-grant and patent litigation challenges to blockbuster biologics. Since the enactment of the Biologics Price Competition and Innovation Act...more

2/27/2025  /  Amgen , Biologics , Biosimilars , BPCIA , Intellectual Property Protection , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , USPTO

Blockbuster Biologics Review | Issue 21

Welcome to our quarterly update relating to biologics and biosimilars, including post-grant and patent litigation challenges to blockbuster biologics. Since the enactment of the Biologics Price Competition and Innovation Act...more

11/3/2023  /  Amgen , Biologics , Biosimilars , BPCIA , Food and Drug Administration (FDA) , Patent Infringement , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Sandoz
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide